Status
Conditions
Treatments
About
The study aims to investigate whether cell-based non-invasive prenatal testing (cbNIPT) can be used as an alternative to invasive chorionic villus sampling (CVS) in patients who achieve pregnancy following preimplantation genetic testing for monogenic disorders (PGT-M).
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
8 participants in 1 patient group
Loading...
Central trial contact
Christian Liebst Frisk Toft, Molecular Biologist
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal